English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Aug 9, 2026

Single-use endoscope developed for gastric cancer screening in Japan
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Research finds singlehood can foster personal growth and self-expansion
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers identify brain cell group that may reduce opioid addiction risk
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Vistagen’s anxiety nasal spray fails to outperform placebo in Phase 2 study
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Artificial intelligence may enhance implementation of new Medicaid work requirements
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Adelaide University launches research program targeting chronic visceral pain
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers use AI to design functional bacteriophage genomes from scratch
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Intellia links liver safety signals in ATTR gene therapy to specific HLA allele

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'